Abstract:Point your SmartPhone at the code above. If you have a QR code reader the video abstract will appear. Or use: https://youtu.be/v9IJgKoCzJM Background: Recently, emerging evidence has indicated crucial roles for long noncoding RNAs (lncRNAs) in breast cancer (BC) development and progression. Our study aimed to investigate the clinical significance of LINC01089 in patients with BC and to determine its biological functions and underlying molecular mechanisms. Materials and methods: Correlations between LINC01089 expression and the clinicopathological characteristics of BC patients were assessed using chi-square tests. The Kaplan-Meier method was used to produce survival curves. The clinical risk characteristics associated with the overall survival and recurrence-free survival of patients with BCwere estimated using univariate and multivariate Cox regression analyses. Several methods were used to determine the expression profile, biological functions and underlying mechanisms of LINC01089 in BC, including cell proliferation assays, colony formation assays, flow cytometry, transwell assays, wound healing assays, quantitative real-time polymerase chain reaction and Western blotting. Results: LINC01089 was downregulated in BC tissues and cell lines. Low LINC01089 expression was significantly correlated with age (P=0.026), lymph node metastasis (P=0.003), and poor prognosis of patients with BC. According to the multivariate Cox regression analysis results, LINC01089 was an independent prognostic indicator of overall survival (P=0.032) and recurrence-free survival (P=0.014). Functional studies revealed significant decreases in the proliferation, migration, and invasion of tumor cells overexpressing LINC01089, and EGF could reverse above effects of LINC01089 on BC cells. Additionally, increased LINC01089 expression promoted apoptosis and cell cycle arrest at G0/G1 phase, accompanied by decreased expression of the key cell cycle regulators CDK4 and CDK6. Loss-of-function assays confirmed partial results. Mechanistically, LINC01089 blocked the Wnt/β-catenin pathway and the expression of downstream target genes by inhibiting β-catenin expression at the transcriptional level. Conclusion: Based on our results, LINC01089 functions as a tumor suppressor and potentially represents a novel prognostic indicator and therapeutic target in BC.

LINC00662 enhances cell progression and stemness in breast cancer by MiR-144-3p/SOX2 axis

Long Noncoding RNA SNHG14 Promotes Breast Cancer Cell Proliferation and Invasion Via Sponging Mir-193A-3p

The oncogenic potentials and diagnostic significance of long non-coding RNA LINC00310 in breast cancer.

LINC01133 Inhibits Breast Cancer Invasion and Metastasis by Negatively Regulating SOX4 Expression Through EZH2

LINC00472 expression is regulated by promoter methylation and associated with disease-free survival in patients with grade 2 breast cancer

Long intergenic noncoding RNA 00641 inhibits breast cancer cell proliferation, migration, and invasion by sponging miR‐194‐5p

LINC01806 Promotes Breast Cancer Growth and Metastasis Via Sponging Mir-1286 to Disinhibit ZEB1 Expression.

LncRNA LINC00466 Promotes the Progression of Breast Cancer via miR-4731-5p/EPHA2 Pathway

LINC00261 / microRNA ‐550a‐3p/ SDPR axis affects the biological characteristics of breast cancer stem cells

LINC01234 Accelerates the Progression of Breast Cancer Via the Mir-525-5p/cold Shock Domain-Containing E1 Axis

LINC01977 Promotes Breast Cancer Progression and Chemoresistance to Doxorubicin by Targeting miR-212-3p/GOLM1 Axis

LINC00665 Stimulates Breast Cancer Progression Via Regulating Mir-551B-5p

Ott_a_208830 4883..4895

Long Noncoding RNA Linc00339 Promotes Triple‐negative Breast Cancer Progression Through Mir‐377‐3p/hoxc6 Signaling Pathway

LINC00461 Overexpression Can Induce Docetaxel Resistance in Breast Cancer by Interacting with miR-411-5p.

A novel long non‐coding RNA LINC00524 facilitates invasion and metastasis through interaction with TDP43 in breast cancer

Long Non-Coding RNA LINC00467 Correlates to Poor Prognosis and Aggressiveness of Breast Cancer

LINC00882, Transcriptionally Activated by CEBP-β and Post-Transcriptionally Stabilized by METTL14-mediated M6a Modification, Exerts Tumorigenesis by Promoting PABPC1-mediated Stabilization of ELK3 Mrna

ETS-1-activated LINC01016 Over-Expression Promotes Tumor Progression Via Suppression of RFFL-mediated DHX9 Ubiquitination Degradation in Breast Cancers

Long non-coding RNA 01088 restrains breast cancer progression via regulating miR-498/PTEN axis

LINC00514 upregulates CCDC71L to promote cell proliferation, migration and invasion in triple‐negative breast cancer by sponging miR-6504-5p and miR-3139